- , ,
This potential interaction has been suggested as a contributing factor in tissue regeneration models
CrossRef The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang BMC Cancer .2025;[Epub] CrossRef Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration Maimaitiming Aimaiti, Dilimulati Maimaitituxun, Xiaokaiti Yilihaer, Talifujiang Kuerban, Junling Zhu, Mieradilijiang Ainiwaer, Zhiqiang Jia, Ainiwaerjiang Abudourousuli Journal of Hepatocellular Carcinoma .2025
Ozempic vs Victoza (Liraglutide) Both Ozempic and Victoza are very similar drugs with both based on human GLP-1
BPC-157 is a synthetic fragment of a protein found in human gastric juice
All experimental techniques followed the guidelines for the Care and Use of Laboratory Animals and were conducted in compliance with the ARRIVE guidelines
